Gilead Sciences, Inc.
- SEC CIK
- 0000882095
- Latest filing
- Aug 3, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 13, 2025. Long positions only.
- Positions
- 16
- No filing for Q3 2024
- Portfolio value
- $1.55B
- No filing for Q3 2024
Gilead Sciences, Inc. did not file a 13F for Q3 2024, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ACLXArcellx, Inc. | COMMON STOCK | 6,720,803 | $515.4M | 33.2% | – | – | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 16,707,477 | $461.7M | 29.8% | – | – | History |
| RCUSArcus Biosciences, Inc. | COM | 30,061,124 | $447.6M | 28.9% | – | – | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 2,209,471 | $34.9M | 2.2% | – | – | History |
| MRUSMerus N.V. | COM | 452,527 | $19.0M | 1.2% | – | – | History |
| KYTXKyverna Therapeutics, Inc. | COM | 4,126,119 | $15.4M | 1.0% | – | – | History |
| CYPHCypherpunk Technologies Inc. | COM NEW | 5,319,148 | $15.3M | 1.0% | – | – | History |
| TNGXTango Therapeutics, Inc. | COM | 4,854,443 | $15.0M | 1.0% | – | – | History |
| XLOXilio Therapeutics, Inc. | COM | 9,105,451 | $8.70M | 0.6% | – | – | History |
| KLRSKalaris Therapeutics, Inc. | COM | 16,635,286 | $6.99M | 0.5% | – | – | History |
| HOOKHOOKIPA Pharma Inc. | COM | 1,875,945 | $3.77M | 0.2% | – | – | History |
| IMAImageneBio, Inc. | COM | 2,008,338 | $3.29M | 0.2% | – | – | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,156,689 | $2.46M | 0.2% | – | – | History |
| BRNSBarinthus Biotherapeutics plc. | ADS | 620,351 | $749.4K | <0.1% | – | – | History |
| AGENAgenus Inc | COM NEW | 231,663 | $634.8K | <0.1% | – | – | History |
| KRONKronos Bio, Inc. | COM | 188,567 | $179.1K | <0.1% | – | – | History |